Acuta Capital Partners’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$1.29M	–	40
2024 Q4	$1.29M	Buy	+50,000	New	+$1.29M	1.29%	25
2024 Q3	–	Sell	-22,500	Closed	-$432K	–	44
2024 Q2	$432K	Buy	+22,500	New	+$432K	0.36%	29